| 摘要 |
<p>The invention disclosed a new kind of polypeptide-human cytoplasmic dynein intermediated chain (IC) 9.35 and the polynucleotide encoding said polypeptide and a process for producing the polypeptide by recombinant methods. It also disclosed the method of applying the polypeptide for the treatment of various kinds of diseases, such as nervous system (sympathetic nervous system and parasympathetic nervous system) disease and developmental disorder. The antagonist of the polypeptide and therapeutic use of the same is also disclosed. In addition, it refers to the use of polynucleotide encoding said human cytoplasmic dynein intermediated chain (IC) 9.35.</p> |
